AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Jalra-M 50mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

USV Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Jalra-M 50mg/850mg Tablet

Metformin/Canagliflozin 50mg/850mg tablets manage elevated blood glucose in patients with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk (heart attack or stroke). Prescribed independently or in conjunction with other antidiabetic therapies, optimal efficacy requires adherence to a balanced diet and consistent exercise. Dosage is individualized based on your health status, glucose readings, and existing medications. Taking it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control prevents long-term complications. Maintaining your prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts disease control. Common adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential risk, especially with concurrent insulin or sulfonylurea use; understand its recognition and treatment. This medication isn't suitable for all individuals. Inform your physician of prior kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before starting treatment. Pregnant or lactating individuals require medical consultation. Interactions with other medications are possible; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Jalra-M 50mg/850mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Jalra-M 50mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Jalra-M 50mg/850mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Jalra-M 50mg/850mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Jalra-M 50mg/850mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Jalra-M 50mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Jalra-M 50mg/850mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Jalra-M 50mg/850mg Tablet works:

The tablet Jalra-M, containing 50mg/850mg, combines two agents to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Jalra-M 50mg/850mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Jalra-M 50mg/850mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Jalra-M 50mg/850mg tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Jalra-M 50mg/850mg tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

The use of Jalra-M 50mg/850mg tablets is likely inadvisable for individuals with hepatic impairment and should be forgone. Physician consultation is recommended.

What if you forget to take Jalra-M 50mg/850mg Tablet :

Should you forget to take your Jalra-M 50mg/850mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jalra-M 50mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Jalra-M 50mg/850mg Tablet

Jalra-M 50mg/850mg Tablets rarely cause hypoglycemia by themselves, but insufficient caloric intake while using them can. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, and shakiness. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Jalra-M 50mg/850mg Tablets. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always seek medical advice before taking any other medication.
Patients with allergies to Jalra-M 50mg/850mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Store this medication in its original, tightly closed container, as directed on the label. Dispose of any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Jalra-M 50mg/850mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is unsuitable for individuals under 18.
Lactic acidosis, a serious medical emergency (also known as MALA or Metformin-associated lactic acidosis), is a potential side effect of Jalra-M 50mg/850mg Tablet. This rare complication arises from excessive blood lactic acid. Because of this risk, its use is contraindicated in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms such as muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Jalra-M 50mg/850mg Tablet and prompt medical attention.
Prolonged use of Jalra-M 50mg/850mg tablets can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia and neurological complications.
Jalra-M 50mg/850mg tablets are safe when used as directed by your doctor. However, even with proper usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your physician.
Jalra-M 50mg/850mg Tablet
360
MRP 416
13% off